Ziad Bakri

Portfolio Manager
Opus 42 Investments

Ziad Bakri is co-portfolio manager of the Health Sciences Strategy in the Global Equity Division at T. Rowe Price. He is chairman of the Investment Advisory Committee of the Health Sciences Fund. Ziad also is a vice president and an Investment Advisory Committee member of several T. Rowe Price diversified equity funds.

Ziad's investment experience began in 2005, and he has been with T. Rowe Price since 2011. Prior to this, Ziad was employed by Cowen and Company as a vice president in equity research, where he covered biotechnology companies. Ziad also was employed by Merrill Lynch in London as a health care investment banking analyst.

Ziad earned a B.S., with first-class honors, from the University of Nottingham and an M.D. from the University of Nottingham Medical School. He also has earned the Chartered Financial Analyst® designation. Ziad is a medical doctor and was an emergency medicine resident at the Royal London Hospital.